SE9303323L - Förfarande för framställning av kristallint botulinumtoxin typ a som terapeutisk medicin - Google Patents

Förfarande för framställning av kristallint botulinumtoxin typ a som terapeutisk medicin

Info

Publication number
SE9303323L
SE9303323L SE9303323A SE9303323A SE9303323L SE 9303323 L SE9303323 L SE 9303323L SE 9303323 A SE9303323 A SE 9303323A SE 9303323 A SE9303323 A SE 9303323A SE 9303323 L SE9303323 L SE 9303323L
Authority
SE
Sweden
Prior art keywords
preparation
toxin
botulinum toxin
therapeutic medicine
toxin type
Prior art date
Application number
SE9303323A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE9303323D0 (sv
Inventor
Genji Sakaguchi
Tomoko Shimizu
Original Assignee
Chiba Prefecture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiba Prefecture filed Critical Chiba Prefecture
Publication of SE9303323D0 publication Critical patent/SE9303323D0/xx
Publication of SE9303323L publication Critical patent/SE9303323L/

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE9303323A 1992-10-28 1993-10-11 Förfarande för framställning av kristallint botulinumtoxin typ a som terapeutisk medicin SE9303323L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4311158A JPH06192296A (ja) 1992-10-28 1992-10-28 治療用医薬品としての結晶ａ型ボツリヌス毒素の製造法。

Publications (2)

Publication Number Publication Date
SE9303323D0 SE9303323D0 (sv) 1993-10-11
SE9303323L true SE9303323L (sv) 1994-04-29

Family

ID=18013801

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9303323A SE9303323L (sv) 1992-10-28 1993-10-11 Förfarande för framställning av kristallint botulinumtoxin typ a som terapeutisk medicin

Country Status (6)

Country Link
JP (1) JPH06192296A (da)
DE (1) DE4335366A1 (da)
DK (1) DK112793A (da)
FR (1) FR2697163B1 (da)
GB (1) GB2272697A (da)
SE (1) SE9303323L (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919665A (en) 1989-10-31 1999-07-06 Ophidian Pharmaceuticals, Inc. Vaccine for clostridium botulinum neurotoxin
GB9120306D0 (en) 1991-09-24 1991-11-06 Graham Herbert K Method and compositions for the treatment of cerebral palsy
US8187612B2 (en) 1993-12-28 2012-05-29 Allergan, Inc. Use of the neurotoxic component of a botulinum toxin for treating a spastic muscle
US6974578B1 (en) 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
US8557256B2 (en) 1993-12-28 2013-10-15 Allergan, Inc. Treatment for cervical dystonia with the neurotoxic component of a botulinum toxin
AU709586B2 (en) * 1994-10-24 1999-09-02 Ophidian Pharmaceuticals, Inc. Vaccine and antitoxin for treatment and prevention of C. difficile disease
JP2003009897A (ja) 2001-07-03 2003-01-14 Keiji Oguma ボツリヌス毒素の分離・精製法
RU2257914C1 (ru) * 2004-03-31 2005-08-10 Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. акад. С.Н. Федорова Министерства Здравоохранения Российской Федерации Способ лечения паралитического косоглазия
CN102614264A (zh) * 2012-05-02 2012-08-01 马守云 一种治疗眼脸痉挛的药物
RU2535115C1 (ru) * 2013-05-15 2014-12-10 Бости Трейдинг Лтд Фармацевтический состав, содержащий нейротоксин ботулина
KR101775682B1 (ko) 2015-11-30 2017-09-06 주식회사 대웅 보툴리눔 독소의 제조방법
WO2024191217A1 (ko) 2023-03-16 2024-09-19 주식회사 대웅 다중모드 크로마토그래피를 이용한 개선된 보툴리눔 독소의 정제방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR940005589B1 (ko) * 1986-04-02 1994-06-21 다이닛뽄세이야꾸 가부시끼가이샤 핵산 또는 엔도톡신의 제거제 및 제거방법
US5053005A (en) * 1989-04-21 1991-10-01 Gary E. Borodic Chemomodulation of curvature of the juvenile spine

Also Published As

Publication number Publication date
JPH06192296A (ja) 1994-07-12
GB2272697A (en) 1994-05-25
GB9321794D0 (en) 1993-12-15
DE4335366A1 (de) 1994-05-05
DK112793D0 (da) 1993-10-08
FR2697163B1 (fr) 1995-06-23
SE9303323D0 (sv) 1993-10-11
FR2697163A1 (fr) 1994-04-29
DK112793A (da) 1994-04-29

Similar Documents

Publication Publication Date Title
SE9303323L (sv) Förfarande för framställning av kristallint botulinumtoxin typ a som terapeutisk medicin
US4876241A (en) Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
DE69434532D1 (de) Verfahren zur Herstellung eines Produktes mit hohem Trehalosegehalt
HU902472D0 (en) Process for the production of freeze-dryed pharmaceutical products containing active agents
IE831068L (en) Heat treatment of lyophilized plasma fractions
SE8602405D0 (sv) Ny formulering
FI98491B (fi) Menetelmä virusinaktivoidun verituotteen valmistamiseksi
ES532075A0 (es) Procedimiento para la inactivacion de germenes patogenos, capaces de reproducirse
Arbuthnott et al. Studies of staphylococcal toxins in relation to toxic epidermal necrolysis (the scalded skin syndrome)
DE58905236D1 (de) Verfahren zur modifizierung von molke.
HRP940645A2 (en) Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained
CA1337688C (en) Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
DE3465880D1 (en) Metabolically active preparations obtained from yeast of any type
RU2113843C1 (ru) Биологически активная добавка для косметических средств
NO881717D0 (no) Fremgangsmaate for fremstilling av et nytt proteolytisk kompleks som stimulerer aktiviteten til bukspyttkjertelen, samt anvendelser derav innenfor dyreoppdrett.
FR2597344B1 (fr) Perfectionnement au procede de purification d'antigenes proteiques de bacteries appartenant au genre bordetella, en vue de l'obtention d'un vaccin acellulaire.
FR2205304A1 (en) Beauty treatment - for the skin with compsn contg cellular material esp rna and dna
KR940003495A (ko) 해조류를 이용한 음료의 제조방법
FI935725A0 (fi) Aktiva mjoelkproteinkomponenter innehaollande produkter och foerfarande foer deras framstaellning
US2433879A (en) Manufacture of amino acid preparations intended for intravenous supply of nutrients
ATE285770T1 (de) Verfahren zur herstellung von carbapenem- antibiotika zubereitungen
BR9500017A (pt) Processo para minimizar a degradação de proteína C ativada e formulação farmacêutica
RU95100951A (ru) Способ лечения мужского бесплодия
DE946061C (de) Verfahren zur enzymatischen Hydrolyse von Eiweissstoffen und Autolyse von tierischen Geweben
SU1197669A1 (ru) Способ лечени нагноительных заболеваний легких

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9303323-1

Format of ref document f/p: F